Does structured support actually reduce weight regain after stopping a GLP-1?

In a new peer reviewed pilot trial, yes, at least over four months. Adults who got either a digital wellness app or medically tailored meals after stopping a GLP-1 regained about 3.6 percent of their body weight, versus 10.75 percent for a usual care group with no added structure. It is the first randomized evidence that structure, not just the drug, is doing real work, though it is one small trial and needs to be replicated.

What did the new GLP-1 weight regain pilot trial actually test?

Hollis-Hansen and colleagues (Obesity Science & Practice, 2026) randomized 39 adults who had lost at least 10 percent of their body weight on a GLP-1 to one of three arms at the moment they stopped the drug: usual care, a generic digital wellness app, or medically tailored meals, followed remotely for four months. Weight change was an exploratory outcome, not the trial's primary endpoint.

Does this prove a coaching app prevents GLP-1 weight regain?

No, and the authors are explicit about that. The sample was small, the digital app used was a general wellness app, not a program built specifically for the GLP-1 off ramp, and both intervention groups still gained some weight. It is the first direct randomized signal that the mechanism works, not proof that any specific program, including ours, beats the odds.

What should I actually do before stopping a GLP-1?

Build the structure before the medication steps back, not after: protein and vegetables at every plate, planned meals instead of wait-and-see ones, regular weigh-ins or check-ins, and continued movement. Any decision about when and how to taper belongs with your prescriber, not a blog post or an app.

Back to Blog

What a New Pilot Trial Found About Preventing Weight Regain After Stopping a GLP-1

A new peer-reviewed pilot trial found structured support cut early weight regain after stopping a GLP-1 to about a third of what usual care saw. Here is what it found, and what it does not yet prove.

Heather Bauer, RD · October 23, 2026

Here is the headline finding, stated plainly: in a new peer reviewed pilot trial, adults who had structured support in place the moment they stopped a GLP-1 regained about a third as much weight over four months as adults who got usual care alone, 3.6 percent versus 10.75 percent. It is a small trial, and it does not prove any specific program works. But it is the first randomized evidence that structure, not the drug itself, is the active ingredient in preventing the post-GLP-1 bounce back, and that is worth taking seriously.

Why this question has gotten so loud

Millions of people are now tapering off a GLP-1, by choice, by cost, or by a prescriber’s plan, and “will I gain it all back” has become one of the most common fears in that transition. Most of what circulates online in response is either reassurance with no data behind it or fatalism with no nuance. A 2026 systematic review and meta-analysis in The BMJ, covering 37 studies and more than 9,300 adults, found regain after stopping a GLP-1 happens faster, on average, than after ending a behavioral program, and that no specific support program had been shown to change that population-level curve (more on what the evidence predicts). This new pilot trial is the first study designed to test that exact question head-on, with a randomized comparison at the actual moment of discontinuation.

What the trial actually tested

Hollis-Hansen and colleagues (Obesity Science & Practice, 2026) enrolled 39 adults who had lost more than 10 percent of their body weight while on a GLP-1 and had stopped taking it within the prior month. At that point, the moment the medication’s appetite effect starts to fade, they were randomized into one of three arms and followed remotely for four months, from March 2024 to August 2025:

Usual care. No added structure beyond whatever the person already had in place.
A digital wellness app. A generic app offering behavioral weight-management strategies (several outlets identified it as Noom), not a program purpose-built for the GLP-1 off-ramp.
Medically tailored meals. Prepared meals delivered to the participant for the four-month window.

Weight change was an exploratory outcome in this trial, not the primary endpoint the study was statistically powered to detect. That matters for how much weight (no pun intended) to put on the exact numbers, and the authors say so themselves.

What the numbers showed

Over four months, the usual care group gained an estimated 10.75 percent of their body weight back. The digital wellness app group gained 3.60 percent. The medically tailored meals group gained 3.58 percent. Both structured arms still regained weight, structure did not stop regain outright, it slowed it to roughly a third of the usual care rate. Diet quality, perceived health, adherence, and satisfaction did not differ significantly between groups, though some measures trended in favor of the app arm.

What this does not prove yet

The limits deserve the same directness as the finding, because a small, honest signal is more useful than an oversold one.

The sample is tiny. Thirty-nine people split across three arms is a pilot, not a definitive trial. The authors themselves call for larger, longer, more diverse studies before anyone treats this as settled.
Weight was a secondary measure. The trial was not built and powered specifically to detect a weight-regain difference, so treat the exact percentages as a strong early signal, not a locked-in effect size.
The app was generic. The digital intervention was an off-the-shelf wellness app, not a tool designed around the specific physiology of coming off a GLP-1. That the effect showed up anyway is the more interesting part of this story, not less.
Both groups still gained weight. No arm in this trial prevented regain completely. Structure changed the slope, not the direction.

How this fits with the bigger picture

This pilot trial does not overturn what the larger body of evidence has found, it adds a new piece to it. The BMJ meta-analysis referenced above looked at existing studies and found no significant population-level effect from “having a support program” in general, a mix of programs, most not designed around this specific transition. This trial is the first to randomize people at the actual moment of stopping a GLP-1 and test structure head-to-head against usual care, and it found a real difference in a mechanism-testing pilot. Early, randomized, and promising is a different category of evidence than large and settled, and both things being true at once is the honest state of the science right now.

The practical takeaway if you are tapering off a GLP-1

None of this requires waiting for a bigger trial to act on. The direction of the evidence, old and new, points the same way: structure in place before the medication steps back matters.

Protein and vegetables leading every plate, the same plate math that works whether or not a medication is involved.
Planned meals instead of wait-and-see ones. Appetite cues are exactly what is shifting during this window, so a plan removes the guesswork at the moment it is least reliable.
Regular weigh-ins or check-ins, so a slow creep gets caught and addressed in weeks, not discovered six months later.
Continued movement, which has its own independent, measurable effect on body composition separate from whatever the scale does.

Any decision about when to taper, how fast, or whether to restart belongs with your prescriber. This is a nutrition and habits conversation, not a dosing one.

The bottom line

A new, small, honestly-limited pilot trial found that structured support cut early weight regain after stopping a GLP-1 to roughly a third of the usual-care rate. It is not proof that any one program, app, or brand, including this one, beats the odds. It is the first direct randomized evidence that the mechanism behind that claim is real, which is exactly the premise this coaching method has been built on long before this trial existed: a plan beats willpower, especially right when your body’s chemistry is changing the fastest. If you are actively tapering, the week-to-week plan for that transition is the practical next read.